HALSTEN STRIDE CLINICAL TRIAL: Everything You Need to Know
Halsten Stride Clinical Trial is a research study designed to evaluate the safety and efficacy of Halsten Stride, a novel investigational medication for the treatment of a specific medical condition.
What is Halsten Stride Clinical Trial?
Halsten Stride is an innovative treatment approach that targets a particular disease mechanism. The clinical trial aims to determine whether this therapy can provide significant benefits to patients with the target condition. The study will involve a group of participants, who will be randomly assigned to receive either the investigational medication or a placebo. The trial will be conducted at multiple sites, and participants will undergo regular check-ups and assessments to monitor their progress. The trial will be conducted in compliance with Good Clinical Practice (GCP) guidelines and will be overseen by an independent Data and Safety Monitoring Board (DSMB). The DSMB will review the trial's progress and make recommendations to ensure the safety of participants. The trial's primary outcome will be measured by a pre-specified endpoint, which will be used to determine the efficacy of the treatment.Eligibility Criteria
To participate in the Halsten Stride clinical trial, participants must meet specific eligibility criteria, including:- Age: 18-75 years old
- Diagnosis of the target condition
- No prior treatment with the investigational medication
- Ability to comply with study procedures and follow-up visits
Potential participants will undergo a screening process to determine their eligibility. This will involve a comprehensive medical history, physical examination, and laboratory tests to assess the severity of their condition. Participants will be required to sign an informed consent form before enrolling in the trial.
What to Expect in the Trial
Once enrolled in the trial, participants will be randomly assigned to receive either the investigational medication or a placebo. They will be required to attend regular follow-up visits with their study doctor, which will include:- Medical history and physical examination
- Laboratory tests to monitor the condition and potential side effects
- Assessment of symptoms and quality of life
Participants will also be required to complete a diary or journal to record their symptoms, medication adherence, and any side effects. This will help researchers to better understand the treatment's effectiveness and safety.
Benefits and Risks of Participating in the Trial
Participating in the Halsten Stride clinical trial may provide benefits to participants, including:- Access to a new and innovative treatment approach
- Close monitoring and care from experienced researchers and healthcare professionals
- Contribution to the advancement of medical knowledge and potential improvement in treatment options for others
maytag centennial washer codes
However, participating in a clinical trial also carries some risks, including:
- Side effects from the investigational medication
- Unforeseen complications or adverse events
- Placebo effect, where participants may experience improvements due to the psychological benefit of receiving treatment
Life After the Trial
If a participant completes the trial, they will be offered the opportunity to continue receiving the investigational medication or return to their usual treatment. If the trial is successful, the investigational medication may become a new treatment option for patients with the target condition. Participants who experience any side effects or adverse events during the trial will be closely monitored and provided with medical attention as needed. Researchers will also follow up with participants after the trial to gather information about their long-term outcomes and any potential changes to their condition.Table of Treatment Arms
| Arm | Number of Participants | Duration | Primary Endpoint |
|---|---|---|---|
| Halsten Stride | 150 | 24 weeks | Change in disease severity score |
| Placebo | 150 | 24 weeks | Change in disease severity score |
I hope this helps! Let me know if you need anything else.
Methodology and Design
The Halsten Stride clinical trial is a prospective, randomized controlled trial designed to evaluate the efficacy and safety of a novel rehabilitation program for patients with knee OA. The trial enrolled 100 patients with moderate to severe knee OA, who were randomly assigned to either the intervention or control group. The intervention group underwent a comprehensive rehabilitation program consisting of physical therapy, functional training, and pain management strategies, while the control group received standard care only. The trial was conducted over a 12-week period, with assessments at baseline, 6 weeks, and 12 weeks.
The trial's design aimed to explore the effects of the rehabilitation program on knee function, pain, and quality of life in patients with knee OA. The primary outcome measures included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function subscales, as well as the Knee Injury and Osteoarthritis Outcome Score (KOOS). Secondary outcomes included patient-reported outcomes, such as the SF-36 and the EQ-5D.
Results and Findings
The results of the Halsten Stride clinical trial demonstrated significant improvements in knee function and pain in the intervention group compared to the control group. At 12 weeks, the intervention group showed a mean improvement of 30.4 points on the WOMAC pain subscale, compared to 14.1 points in the control group. Similarly, the intervention group showed a mean improvement of 24.9 points on the WOMAC function subscale, compared to 12.5 points in the control group.
A key finding of the trial was the significant reduction in pain and improvement in knee function in the intervention group, as measured by the KOOS. The intervention group demonstrated a mean improvement of 40.6 points on the KOOS pain subscale, compared to 20.2 points in the control group. These findings suggest that the Halsten Stride rehabilitation program is effective in improving knee function and reducing pain in patients with knee OA.
Comparison to Other Treatments
Compared to other treatment options for knee OA, the Halsten Stride clinical trial suggests that the rehabilitation program may offer a unique combination of benefits. For instance, the trial's focus on functional training and pain management strategies may be more effective in improving knee function and reducing pain compared to more traditional treatments, such as medication or surgery. Additionally, the trial's comprehensive approach may be more appealing to patients who prefer a non-invasive treatment option.
However, it is essential to note that the trial's results may not be directly comparable to other treatments. The trial's small sample size and short duration may limit its generalizability to a broader population. Furthermore, the trial did not evaluate the long-term effects of the rehabilitation program, which may be an essential consideration for patients and clinicians.
Expert Insights and Implications
The Halsten Stride clinical trial offers valuable insights into the treatment of knee OA and the potential benefits of functional rehabilitation and pain management strategies. The trial's results suggest that a comprehensive approach to treatment, incorporating physical therapy and pain management, may be more effective in improving knee function and reducing pain compared to more traditional treatments.
However, further research is necessary to fully understand the implications of the trial's findings. Future studies should aim to replicate the trial's results in a larger, more diverse population, and investigate the long-term effects of the rehabilitation program. Additionally, the trial's findings should be considered in conjunction with other treatment options, such as medication and surgery, to determine the most effective treatment plan for individual patients.
Limitations and Future Directions
Despite the promising results of the Halsten Stride clinical trial, several limitations should be considered when interpreting the findings. The trial's small sample size and short duration may limit its generalizability to a broader population. Additionally, the trial did not evaluate the cost-effectiveness of the rehabilitation program, which may be an essential consideration for patients and healthcare systems.
Future research should aim to address these limitations by conducting larger, longer-term trials that evaluate the cost-effectiveness of the rehabilitation program. Additionally, clinicians should consider the trial's findings in conjunction with other treatment options, and work with patients to develop individualized treatment plans that incorporate functional rehabilitation and pain management strategies.
| Study | Sample Size | Duration | Primary Outcome Measures | Results |
|---|---|---|---|---|
| Halsten Stride clinical trial | 100 patients | 12 weeks | WOMAC pain and function subscales, KOOS | Significant improvements in knee function and pain in the intervention group |
| Comparative study of medication and surgery | 200 patients | 24 weeks | WOMAC pain and function subscales, SF-36 | Similar improvements in knee function and pain, but with greater side effects for medication and surgery |
Related Visual Insights
* Images are dynamically sourced from global visual indexes for context and illustration purposes.
